Drug intelligence / Profile preview

liqi shuxin tablets

Development stage
Unknown
Lead developer
Jilin Fukang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Liqi Shuxin Tablets is a Traditional Chinese Medicine (TCM) product manufactured by Jilin Fukang Pharmaceutical. It is formulated to regulate Qi circulation and soothe the heart, making it primarily indicated for cardiovascular disorders such as coronary heart disease and angina pectoris. The medication is typically used to treat symptoms including chest tightness, palpitations, and shortness of breath, which are attributed to Qi stagnation and blood stasis in TCM theory. The formulation consists of a complex blend of herbal ingredients, including *Cyperus rotundus*, *Citrus aurantium*, and *Ligusticum chuanxiong*, which are traditionally recognized for their analgesic and circulation-promoting properties. It is administered orally and is currently approved and marketed in China.

Brand names
理气舒心片
Other names
Liqi Shuxin PianLiqi Shuxin Tablets

Beyond the preview

Go deeper on liqi shuxin tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liqi shuxin tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call